These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 34178414)
61. Human Nasal and Lung Tissues Infected Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170 [TBL] [Abstract][Full Text] [Related]
62. Organoids and Microphysiological Systems: New Tools for Ophthalmic Drug Discovery. Bai J; Wang C Front Pharmacol; 2020; 11():407. PubMed ID: 32317971 [TBL] [Abstract][Full Text] [Related]
63. Biomimetic lung-on-a-chip to model virus infection and drug evaluation. Tan J; Guo Q; Tian L; Pei Z; Li D; Wu M; Zhang J; Gao X Eur J Pharm Sci; 2023 Jan; 180():106329. PubMed ID: 36375766 [TBL] [Abstract][Full Text] [Related]
64. Imaging microphysiological systems: a review. Peel S; Jackman M Am J Physiol Cell Physiol; 2021 May; 320(5):C669-C680. PubMed ID: 33356942 [TBL] [Abstract][Full Text] [Related]
65. Beyond Polydimethylsiloxane: Alternative Materials for Fabrication of Organ-on-a-Chip Devices and Microphysiological Systems. Campbell SB; Wu Q; Yazbeck J; Liu C; Okhovatian S; Radisic M ACS Biomater Sci Eng; 2021 Jul; 7(7):2880-2899. PubMed ID: 34275293 [TBL] [Abstract][Full Text] [Related]
66. Human microphysiological models of airway and alveolar epithelia. Lagowala DA; Kwon S; Sidhaye VK; Kim DH Am J Physiol Lung Cell Mol Physiol; 2021 Dec; 321(6):L1072-L1088. PubMed ID: 34612064 [TBL] [Abstract][Full Text] [Related]
67. Microphysiological Systems: A Pathologist's Perspective. Sura R; Van Vleet T; Berridge BR Vet Pathol; 2020 May; 57(3):358-368. PubMed ID: 32180532 [TBL] [Abstract][Full Text] [Related]
68. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients. Rogers CJ; Harman RJ; Bunnell BA; Schreiber MA; Xiang C; Wang FS; Santidrian AF; Minev BR J Transl Med; 2020 May; 18(1):203. PubMed ID: 32423449 [TBL] [Abstract][Full Text] [Related]
69. Opportunities and challenges in the wider adoption of liver and interconnected microphysiological systems. Hughes DJ; Kostrzewski T; Sceats EL Exp Biol Med (Maywood); 2017 Oct; 242(16):1593-1604. PubMed ID: 28504617 [TBL] [Abstract][Full Text] [Related]
70. Spheroids and organoids as humanized 3D scaffold-free engineered tissues for SARS-CoV-2 viral infection and drug screening. Kronemberger GS; Carneiro FA; Rezende DF; Baptista LS Artif Organs; 2021 Jun; 45(6):548-558. PubMed ID: 33264436 [TBL] [Abstract][Full Text] [Related]
71. A Biosafety Level 2 Mouse Model for Studying Betacoronavirus-Induced Acute Lung Damage and Systemic Manifestations. Andrade ACDSP; Campolina-Silva GH; Queiroz-Junior CM; de Oliveira LC; Lacerda LSB; Pimenta JC; de Souza FRO; de Meira Chaves I; Passos IB; Teixeira DC; Bittencourt-Silva PG; Valadão PAC; Rossi-Oliveira L; Antunes MM; Figueiredo AFA; Wnuk NT; Temerozo JR; Ferreira AC; Cramer A; Oliveira CA; Durães-Carvalho R; Weis Arns C; Guimarães PPG; Costa GMJ; de Menezes GB; Guatimosim C; da Silva GSF; Souza TML; Barrioni BR; Pereira MM; de Sousa LP; Teixeira MM; Costa VV J Virol; 2021 Oct; 95(22):e0127621. PubMed ID: 34495692 [TBL] [Abstract][Full Text] [Related]
72. Review of studies of severe acute respiratory syndrome related coronavirus-2 pathogenesis in human organoid models. Egilmezer E; Rawlinson WD Rev Med Virol; 2021 Nov; 31(6):e2227. PubMed ID: 33763936 [TBL] [Abstract][Full Text] [Related]
73. Mechanical ventilation in COVID-19: A physiological perspective. Cronin JN; Camporota L; Formenti F Exp Physiol; 2022 Jul; 107(7):683-693. PubMed ID: 34541721 [TBL] [Abstract][Full Text] [Related]
74. SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery. Mulay A; Konda B; Garcia G; Yao C; Beil S; Villalba JM; Koziol C; Sen C; Purkayastha A; Kolls JK; Pociask DA; Pessina P; de Aja JS; Garcia-de-Alba C; Kim CF; Gomperts B; Arumugaswami V; Stripp BR Cell Rep; 2021 May; 35(5):109055. PubMed ID: 33905739 [TBL] [Abstract][Full Text] [Related]
75. Integrated Gut and Liver Microphysiological Systems for Quantitative In Vitro Pharmacokinetic Studies. Tsamandouras N; Chen WLK; Edington CD; Stokes CL; Griffith LG; Cirit M AAPS J; 2017 Sep; 19(5):1499-1512. PubMed ID: 28752430 [TBL] [Abstract][Full Text] [Related]
76. Three-Dimensional Cell Cultures as a Research Platform in Lung Diseases and COVID-19. da Silva da Costa FA; Soares MR; Malagutti-Ferreira MJ; da Silva GR; Lívero FADR; Ribeiro-Paes JT Tissue Eng Regen Med; 2021 Oct; 18(5):735-745. PubMed ID: 34080133 [TBL] [Abstract][Full Text] [Related]
77. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice. Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A mBio; 2021 Apr; 12(2):. PubMed ID: 33879586 [TBL] [Abstract][Full Text] [Related]
78. Stem cell-derived organoid models for SARS-CoV-2 and its molecular interaction with host cells. Dawoody Nejad L; Julian LM Mol Biol Rep; 2023 Dec; 50(12):10627-10635. PubMed ID: 37740859 [TBL] [Abstract][Full Text] [Related]
79. Tissue Chips to aid drug development and modeling for rare diseases. Low LA; Tagle DA Expert Opin Orphan Drugs; 2016; 4(11):1113-1121. PubMed ID: 28626620 [TBL] [Abstract][Full Text] [Related]
80. Microphysiological systems in early stage drug development: Perspectives on current applications and future impact. Kopec AK; Yokokawa R; Khan N; Horii I; Finley JE; Bono CP; Donovan C; Roy J; Harney J; Burdick AD; Jessen B; Lu S; Collinge M; Sadeghian RB; Derzi M; Tomlinson L; Burkhardt JE J Toxicol Sci; 2021; 46(3):99-114. PubMed ID: 33642521 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]